Melarsomine Dihydrochloride 50 Mg/ Injection
48 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
48
Total Reports
2
Deaths Reported
420.0%
Death Rate
Active Ingredients
Melarsomine Dihydrochloride 50 Mg/ Injection
Administration Routes
IntramuscularUnknownIntravenousParenteral
Species Affected
Dog 48
Most Affected Breeds
Beagle 5
Terrier - Bull - American Pit 4
Terrier (unspecified) 3
Retriever - Golden 3
Retriever - Labrador 3
Chihuahua 3
Collie - Border 2
Crossbred Canine/dog 2
Bulldog - French 2
Shepherd Dog - German 2
Most Reported Reactions
Lack of efficacy (endoparasite) - heartworm 20
Vomiting 7
Panting 6
Diarrhoea 5
Shaking 3
Injection site lump 3
Limb weakness 3
Pain NOS 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Injection site pain 2
Lethargy (see also Central nervous system depression in Neurological) 2
Injection site swelling 2
Outcome Breakdown
Outcome Unknown
31 (64.6%)
Recovered/Normal
8 (16.7%)
Ongoing
7 (14.6%)
Died
2 (4.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.